Abstrakt
Technological advancements of left ventricular assist devices (LVAD) have created today's potential for extending the lives of patients with end-stage heart failure. Few studies have examined the effect of LVAD therapy on patient-reported outcomes (PROs), such as health status, quality of life, and anxiety/depression, despite poor PROs predicting mortality and rehospitalization in patients with heart failure. In this systematic review, we provide an overview of available evidence on the impact of LVAD therapy on PROs and discuss recommendations for clinical research and practice.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Circulation. Heart Failure |
Vol/bind | 4 |
Udgave nummer | 6 |
Sider (fra-til) | 714-23 |
Antal sider | 10 |
ISSN | 1941-3289 |
DOI | |
Status | Udgivet - nov. 2011 |